
-
Marker Therapeutics NASDAQ:MRKR
Location: 5 W Forsyth St Ste 200, Florida, 32202-3676, US | Website: https://www.tapimmune.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
5.01M
Cash
9.00M
Avg Qtr Burn
-2.144M
Short % of Float
4.27%
Insider Ownership
9.85%
Institutional Own.
41.79%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MT-401 Details Acute myeloid leukemia | Phase 2 Data readout | |
Neldaleucel/ MT-601 Details Non-Hodgkin lymphoma, Cancer | Phase 1 Data readout | |
Neldaleucel /MT-601 (w/ chemotherapy) Details Pancreatic cancer | Phase 1 Initiation | |
MT-401-OTS Details Acute myeloid leukemia | Phase 1 Initiation |